Flavin reductase: Difference between revisions
Jump to navigation
Jump to search
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
(3 intermediate revisions by 2 users not shown) | |||
Line 11: | Line 11: | ||
== Structural insights == | == Structural insights == | ||
The <scene name='49/490853/Cv/ | The <scene name='49/490853/Cv/4'>NADP containing active site can accommodate a variety of ligands</scene> because the binding is achieved mainly via hydrophobic interactions ({{Template:ColorKey_Hydrophobic}}, {{Template:ColorKey_Polar}}).<ref>PMID:11224564</ref> | ||
</StructureSection> | </StructureSection> | ||
Line 19: | Line 19: | ||
{{#tree:id=OrganizedByTopic|openlevels=0| | {{#tree:id=OrganizedByTopic|openlevels=0| | ||
*NADPH-dependent Flavin reductase | *NADPH-dependent Flavin reductase or biliverdin IX beta reductase | ||
**[[ | **[[1hdo]], [[7er6]] - hFR + NADP - human<br /> | ||
**[[6opl]] – hFR (mutant) + NADP <br /> | |||
**[[ | |||
**[[1he2]] - hFR + biliverdin IX α + NADP<BR /> | **[[1he2]] - hFR + biliverdin IX α + NADP<BR /> | ||
**[[1he3]] - hFR + mesobiliverdin IV α + NADP<BR /> | **[[1he3]] - hFR + mesobiliverdin IV α + NADP<BR /> | ||
Line 31: | Line 29: | ||
**[[5ooh]] – hFR + NADP + erythrosine<br /> | **[[5ooh]] – hFR + NADP + erythrosine<br /> | ||
**[[5oog]] – hFR + NADP + phloxine + cyanosine<br /> | **[[5oog]] – hFR + NADP + phloxine + cyanosine<br /> | ||
**[[7er7]], [[7er8]], [[7er9]], [[7era]], [[7erb]], [[7erc]], [[7erd]], [[7ere]] – hFR + NADP + drug<br /> | |||
**[[3pft]] - FR (mutant) + FMN – ''Mycobacterium goodii''<br /> | **[[3pft]] - FR (mutant) + FMN – ''Mycobacterium goodii''<br /> | ||
**[[5cho]] - FR + FAD – uncultured bacteria<br /> | **[[5cho]] - FR + FAD – uncultured bacteria<br /> | ||
**[[1qfj]] – FR – ''Escherichia coli''<br /> | |||
**[[1bkj]] – VhFR + FMN – ''Vibrio harveyi''<br /> | |||
**[[2bkj]] - VhFR + NAD + FMN<br /> | |||
* | *NADH-dependent Flavin reductase | ||
**[[1rz0]] – GtFR + FAD – ''Geobacillus thermoglucosidasius''<br /> | **[[1rz0]] – GtFR + FAD – ''Geobacillus thermoglucosidasius''<br /> | ||
Line 41: | Line 43: | ||
**[[4uth]] - PpFR (mutant) + FMN <br /> | **[[4uth]] - PpFR (mutant) + FMN <br /> | ||
**[[5lnj]], [[5lni]], [[4uti]], [[4utj]] - PpFR (mutant) + FMN derivative + coumarin derivative<br /> | **[[5lnj]], [[5lni]], [[4uti]], [[4utj]] - PpFR (mutant) + FMN derivative + coumarin derivative<br /> | ||
**[[2d36]] - StFR + FMN – ''Sulfurisphaera tokodaii''<br /> | |||
**[[2d37]] - StFR + FMN + NAD<br /> | |||
**[[2d38]] - StFR + FMN + NADP<br /> | |||
}} | }} |
Latest revision as of 12:10, 6 March 2023
FunctionFlavin reductase (FR) catalyzes the NADPH-dependent reduction of a variety of flavins such as riboflavin, FAD, FMN, biliverdin, methemoglobin and pyrroloquinoline quinone. FR converts reduced riboflavin to riboflavin and bilirubin to biliverdin. FR is involved in heme catabolism[1] . RelevanceFR catalytic reaction is the basis of the therapeutic use of methylene blue or riboflavin in the treatment of methemoglobinemia. Bacterial FR are used to sensitize tumors to drugs. Structural insightsThe because the binding is achieved mainly via hydrophobic interactions (Hydrophobic, Polar).[2] |
|
3D structures of flavin reductase3D structures of flavin reductase
Updated on 06-March-2023
ReferencesReferences
- ↑ Yubisui T, Takeshita M, Yoneyama Y. Reduction of methemoglobin through flavin at the physiological concentration by NADPH-flavin reductase of human erythrocytes. J Biochem. 1980 Jun;87(6):1715-20. PMID:7400118
- ↑ Pereira PJ, Macedo-Ribeiro S, Parraga A, Perez-Luque R, Cunningham O, Darcy K, Mantle TJ, Coll M. Structure of human biliverdin IXbeta reductase, an early fetal bilirubin IXbeta producing enzyme. Nat Struct Biol. 2001 Mar;8(3):215-20. PMID:11224564 doi:10.1038/84948